Male fertility as a marker for health.


Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
01 2022
Historique:
received: 22 06 2021
revised: 21 09 2021
accepted: 23 09 2021
pubmed: 2 12 2021
medline: 19 4 2022
entrez: 1 12 2021
Statut: ppublish

Résumé

Male reproduction is a complex biological process, and male factor infertility is increasingly recognized as a biomarker for overall male health. Emerging data suggest associations between male reproduction and medical disease (genetic, infectious, chronic comorbid conditions), psychological disease, environmental exposures, dietary habits, medications and substances of abuse, and even socioeconomic factors. There is also evidence that a diagnosis of male fertility is associated with future disease risk including cancer, metabolic disease and mortality. As such, there is a growing view that the male fertility evaluation is an opportunity to improve a man's health beyond his immediate reproductive goals, and also highlights the necessity of a multidisciplinary approach.

Identifiants

pubmed: 34848151
pii: S1472-6483(21)00483-1
doi: 10.1016/j.rbmo.2021.09.023
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

131-144

Informations de copyright

Copyright © 2021 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Tony Chen (T)

Center for Academic Medicine, Stanford University School of Medicine, Palo Alto CA, USA. Electronic address: chentony@stanford.edu.

Federico Belladelli (F)

Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.

Francesco Del Giudice (F)

Sapienza Università di Roma, Rome, Italy.

Michael L Eisenberg (ML)

Center for Academic Medicine, Stanford University School of Medicine, Palo Alto CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH